ABSTRACT
T
he human entorhinal cortex (EC) plays an integral role in memory formation and serves as the critical gateway between the hippocampus and neocortex. 1 Located in the medial temporal lobe, the EC constitutes the anterior portion of the parahip-pocampal gyrus and is localized in vivo laterally by the rhinal sulcus, anteriorly by the amygdala and hippocampus, and posteriorly by the posterior portion of the parahippocampal gyrus. 2, 3 The EC is one of the earliest affected regions in Alzheimer disease (AD). Tau-associated neurofibrillary tangle pathology in AD follows a defined topographic and hierarchical pattern, first affecting the EC and then progressing to anatomically connected limbic and association cortices; in contrast, amyloid-␤-associated pathology does not involve the EC in the earliest stages of AD but selectively affects the neocortical regions. 4, 5 Most important, the association of neuronal volume loss in the EC has been shown to parallel -associated tangle pathology (neurofibrillary tangles and neuritic plaques) but not senile plaques seen with amyloid-␤ deposition. 4 Structural MR imaging provides visualization and quantification of volume loss and has been extensively investigated in AD. [6] [7] [8] [9] Using manually delineated assessments, early studies have shown that volumetric measures of the EC can identify individuals without dementia in the earliest stages of the AD process. [7] [8] [9] Within the past decade, rapid advances in MR imaging postprocessing have led to the development of software tools for automatic quantification of human subcortical and neocortical regions. 10 We have previously developed an MR imaging-based parcellation atlas for the human cerebral cortex, which has automatically delineated the entorhinal cortex. 11 The EC ROI from our parcellation atlas correlates with CSF levels of , amyloid, 12 and Apolipoprotein E 13 and has been used to identify cognitively healthy 14 and cognitively impaired individuals without dementia who are most likely to progress to clinical AD. 15, 16 However, whether our antemortem MR imaging-based measure of the EC is associated with established postmortem measures of AD pathology is still unknown.
In this study, we evaluated the relationship between antemortem MR imaging-based automated measurements of EC thickness and postmortem measures of neurofibrillary tangle and amyloid-␤ pathology. To assess the specificity of our EC ROI (anterior portion of the parahippocampal gyrus), we also evaluated the relationship between the thickness of the posterior parahippocampal gyrus and EC amyloid-␤ and pathology.
MATERIALS AND METHODS

Participants
We evaluated participants from the Rush Memory and Aging Project, a community-based longitudinal study of aging, which began in 1997. 17 Details of the clinical and neuropathologic evaluations have been reported previously. 17, 18 Briefly, all participants underwent a uniform structured clinical evaluation that included a medical history, physical examination with emphasis on neurologic function, and neuropsychological testing (including the Mini-Mental State Examination and 20 other tests). All participants were evaluated in person by a neuropsychologist and a physician with expertise in the evaluation of older individuals with cognitive impairment. On the basis of physician evaluation and review of the cognitive testing and the neuropsychologist's opinion, participants were classified with respect to AD and other common conditions with the potential to impact cognitive function according to the recommendations of the joint working group of the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association. 19 In this article, we focused on 50 participants, clinically defined at baseline (on study entry) as being cognitively healthy (n ϭ 25), having mild cognitive impairment (n ϭ 18), and having probable AD (n ϭ 7) ( Table) , with concurrent antemortem MR imaging and postmortem neuropathologic assessments. The Rush University Medical Center institutional review board approved the study, and all participants gave written informed consent and signed an Anatomic Gift.
Imaging Assessments
We assessed previously obtained T1-weighted anatomic data by using a 1.5T MR imaging scanner (GE Healthcare, Milwaukee, Wisconsin). For the current study, all antemortem MR imaging data were acquired by using a 3D magnetization-prepared rapid acquisition of gradient echo sequence with the following parameters: TE ϭ 2.8 ms, TR ϭ 6.3 ms, preparation time ϭ 1000 ms, flip angle ϭ 8°, FOV ϭ 24 ϫ 24 cm, 160 sections, 1-mm section thickness, a 224 ϫ 192 acquisition matrix reconstructed to 256 ϫ 256, and 2 repetitions. The MR imaging data were automatically segmented with FreeSurfer 5.0 (http://surfer.nmr.mgh.harvard. edu; for additional details see McKhann et al 19 ) . Here, we focused on intracranial volume-corrected average thickness of the entire entorhinal cortex and posterior parahippocampal gyrus (average of the left and right hemispheres) as delineated with our previously developed automated cortical parcellation atlas (DesikanKilliany atlas in Freesurfer) (Fig 1) . 11 In secondary analyses, we also evaluated baseline intracranial volume-corrected hippocampal volumes (average of the left and right hemispheres).
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Neuropathologic Assessments
We used results from previously obtained neuropathologic evaluations and focused on amyloid and neurofibrillary tangle pathology within the entorhinal cortex and medial temporal (entorhinal and hippocampal) regions (for additional details on neuropathologic measures from the Rush Memory and Aging Project/Rush University Medical Center, please see Bennett et al 21, 22 and Barnes et al 23 ) . Briefly, at least 2 tissue blocks from the entorhinal cortex and hippocampus (CA1/subiculum) were dissected from 1-cm coronal slabs fixed for 48 -72 hours in 4% paraformaldehyde, embedded in paraffin, and cut into 20-m sections. Amyloid-␤ was labeled with MO0872 (1:100; Dako, Carpinteria, California), and paired helical filament was labeled with AT8 (1:800 in 4% horse serum; Innogenex, San Ramon, California), an antibody specific for phosphorylated . Images of amyloid-␤-stained sections were captured for quantitative analysis by using a systematic random-sampling scheme, and calculation of the percentage area occupied by amyloid-␤ immunoreactive pixels was performed. Quantification of tangle density per square millimeter was performed with a stereologic mapping station. We used composite summary measures of the percentage area occupied by amyloid-␤ and the density of neurofibrillary tangles by averaging the values for each lesion within the entorhinal cortex and medial temporal regions (entorhinal cortex and hippocampus) (for additional details see Bennett et al 21, 22 and Barnes et al 23 ). To evaluate neuropathology within the neocortex and to minimize multiple comparisons, we used a composite measure of tangle density and amyloid-␤ load within the midfrontal cortex, inferior temporal gyrus, inferior parietal cortex, calcarine cortex, cingulate region, and superior frontal gyrus (cortical tangle density and cortical amyloid-␤ load).
Statistical Analysis
Using linear regression, we evaluated the association between entorhinal cortex thickness and average tangle and amyloid-␤ load within the entorhinal cortex and medial temporal regions (entorhinal cortex ϩ hippocampus). We also evaluated the relationship between entorhinal cortex thickness and cortical tangle density and amyloid-␤ load. In secondary analyses, we assessed the association between (posterior) parahippocampal gyrus thickness and tangles and amyloid-␤ load within the entorhinal cortex and medial temporal regions. In all analyses, we controlled for the effects of age at death, sex, and clinical diagnosis.
RESULTS
We found a relationship between antemortem entorhinal cortex thickness and postmortem tangle density within the entorhinal cortex (␤-coefficient ϭ Ϫ11.04, standard error [SE] ϭ 3.78, P value ϭ .006) and medial temporal regions (␤-coefficient ϭ Ϫ16.67, SE ϭ 5.04, P ϭ .002); lower EC thickness was associated with increased EC and medial temporal lobe tangle density (Fig 2) . Even after controlling for the effects of hippocampal volume, the relationship between entorhinal cortex thickness and tangle density within the entorhinal cortex (␤-coefficient ϭ Ϫ9.36, SE ϭ 2.57, P ϭ .03) and medial temporal regions (␤-coefficient ϭ Ϫ12.89, SE ϭ 5.64, P ϭ .02) remained significant. We found no relationship between entorhinal cortex thickness and amyloid-␤ load within the entorhinal cortex (␤-coefficient ϭ Ϫ4.69, SE ϭ 2.70, P ϭ .09) and medial temporal regions (␤-coefficient ϭ Ϫ3.27, SE ϭ 1.90, P ϭ .09) (Fig 2) .
We found a relationship between entorhinal cortex thickness and both cortical tangle density (␤-coefficient ϭ Ϫ37.5, SE ϭ 12.2, P ϭ .0003) and amyloid-␤ load (␤-coefficient ϭ Ϫ44.9, SE ϭ 17.2, P ϭ .01) (Fig 3) . Even after we controlled for the effects of hippocampal volume, the relationship between entorhinal cortex and both cortical tangle density (␤-coefficient ϭ Ϫ34.4, SE ϭ 7.9, P ϭ .01) and amyloid-␤ load (␤-coefficient ϭ Ϫ44.7, SE ϭ 18.6, P ϭ .02) remained significant.
In contrast, we found no relationship between antemortem parahippocampal gyrus thickness and postmortem tangle density within the entorhinal cortex (␤-coefficient ϭ Ϫ4.04, SE ϭ 4.33, P ϭ .31) and a trend toward significance for the medial temporal regions (␤-coefficient ϭ Ϫ11.52, SE ϭ 5.71, P ϭ .051). Similarly, we found no relationship between parahippocampal gyrus thickness and amyloid load within the entorhinal cortex (␤-coefficient ϭ 1.02, SE ϭ 2.71, P ϭ .709) and medial temporal regions (␤-coefficient ϭ 0.57, SE ϭ 1.91, P ϭ .766). We also found no relationship between parahippocampal gyrus thickness and cortical tangle density (␤-coefficient ϭ Ϫ14.2, SE ϭ 13.5, P ϭ .30) and amyloid-␤ load (␤-coefficient ϭ Ϫ8.7, SE ϭ 18.6, P ϭ .64).
We performed subgroup analyses within our subset of cognitively healthy older participants (n ϭ 25) to evaluate the relationship between MR imaging measures of entorhinal cortex thickness and neuropathology. Similar to our main results, we found a relationship between antemortem entorhinal cortex thickness and postmortem tangle density within the entorhinal cortex (␤-coefficient ϭ Ϫ10.32, SE ϭ 4.03, P ϭ .01), medial temporal regions (␤-coefficient ϭ Ϫ14.48, SE ϭ 6.61, P ϭ .04), and cortex (␤-coefficient ϭ Ϫ16.58, SE ϭ 7.03, P ϭ .02). In contrast, we found no relationship between entorhinal cortex thickness and amyloid load either within the entorhinal cortex (␤-coefficient ϭ Ϫ5.04, SE ϭ 3.91, P ϭ .23) or cortex (␤-coefficient ϭ Ϫ32.26, SE ϭ 22.79, P ϭ .12).
DISCUSSION
Our results demonstrate that quantitative in vivo volumetric MR imaging measurements of the EC are associated with postmortem measures of entorhinal and neocortical AD pathology. Specifically, these results indicate that lower EC thickness predicts higher postmortem tangle load. We also found a similar association between EC thickness and postmortem tangle load within the medial temporal regions (EC ϩ hippocampus). Most important, this effect remained significant after controlling for hippocampal volume. Finally, we found a robust relationship between EC thickness and cortical tangle and amyloid-␤ pathology. Rather than representing a specific measure of EC tangle pathology, our combined findings suggest that an antemortem MR imaging measure of the entorhinal cortex likely captures Alzheimer-associated pathology within the medial temporal and neocortical regions.
Using neuropathologic assessments from the same individuals and building on our prior work, 12, 14 this study suggests that EC-associated cortical thinning in AD may represent a marker of -associated pathology within both the entorhinal cortex and neocortex. Consistent with the known pattern of amyloid-␤ deposition in AD, which heavily involves the neocortex with relative sparing of the entorhinal cortex, an association was found between EC thickness and neocortical amyloid-␤ load but not entorhinal amyloid pathology, compatible with the hypothesis that amyloid deposition within the neocortex, rather than the EC may represent an early component of Alzheimer pathobiology. 24, 25 Our results also suggest that entorhinal cortex thickness may provide independent information about AD pathology even after accounting for hippocampal volume, further illustrating the importance of evaluating EC thickness as an early marker of in vivo Alzheimer neurodegeneration. Most interesting, even among cognitively healthy older adults, we found a selective relationship between entorhinal cortex thickness and tangle pathology but not amyloid pathology, suggesting the potential usefulness of quantitative MR imaging measures in preclinical AD. Accumulating evidence suggests that pathology is closely associated with cognitive performance, particularly in the early stages of disease. 26, 27 These findings suggest that automated measures of entorhinal cortex atrophy may reflect regional pathology, which will be clinically useful for early AD detection and disease monitoring. Additionally, quantitative measures of EC and medial temporal structures may be combined with genetic, fluid (CSF or plasma), and cognitive parameters for risk stratification, which may become increasingly relevant for AD prevention and therapeutic trials. With the advent and use of novel agents for detecting in vivo deposition, 28 volumetric MR imaging could be integrated with PET imaging to determine whether regional measures of entorhinal atrophy and deposition provide independent or complementary information. Finally, beyond AD, automated assessments of the entorhinal cortex can be useful in other disorders of the medial temporal lobe such as medial temporal sclerosis, vascular dementia, and frontotemporal lobar degeneration.
A potential limitation of our study is that our imaging and neuropathology datasets were not coregistered; thus, this drawback limits the precise correspondence between antemortem and postmortem definitions of the EC. Another limitation is the need for validation of our results in independent, community-based samples.
CONCLUSIONS
We found a strong association between an automated, antemortem MR imaging-based measure of EC thickness and postmortem neurofibrillary tangle burden within the entorhinal cortex, medial temporal lobe, and neocortex. We additionally detected a relationship between EC thickness and neocortical amyloid-␤ load. Considered together, our findings serve as a validation of our automated MR imaging measure of the EC and suggest that EC-associated cortical thinning in AD may represent a marker of medial temporal and neocortical AD neuropathology.
